$PRAN News U.S. stocks

New Post Public Reply Private Reply Replies (0) Message Board

Dec 8, 2014 at 12:20 PM

$PRAN News

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains
3:47 p.m. March 31, 2014
- Anora Mahmudova

Keurig biggest S&P 500 loser; BlackBerry extends losses
2:30 p.m. March 31, 2014
- Sue Chang

Biotech's shares fall 70% on tests

11:39 a.m. March 31, 2014
- Russ Britt

U.S. stock futures extend gains ahead of Yellen
7:58 a.m. March 31, 2014
- Barbara Kollmeyer

U.S.-listed shares of Prana sink after drug trial
6:50 a.m. March 31, 2014
- Saumya Vaishampayan

Prana sinks 62% after Alzheimer's study fails
6:22 a.m. March 31, 2014
- Barbara Kollmeyer

U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova

Forest Laboratories, Actavis surge on buyout deal
4:11 p.m. Feb. 18, 2014
- Sue Chang

S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap

4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com

Prana's wild ride continues with shares surging on drug test results

3:24 p.m. Feb. 18, 2014
- Russ Britt

Prana's Huntington disease therapy meets endpoints
11:51 a.m. Feb. 18, 2014
- MarketWatch.com

Prana Biotechnology up 19% in premarket
8:58 a.m. Dec. 6, 2012
- Steve Gelsi

Prana has OK for Alzheimer's study; shares rise
1:30 p.m. Nov. 22, 2011
- MarketWatch.com

Monday’s biggest gaining and declining stocks
3:30 p.m. Sept. 19, 2011
- Laura Mandaro

Prana, European drug makers lead rally
2:26 p.m. April 20, 2011
- Val Brickates Kennedy

Prana climbs 14% on business update
10:18 a.m. April 20, 2011
- Val Brickates Kennedy

Xoma, Prana lead biotech stocks south
12:19 p.m. March 23, 2011
- Val Brickates Kennedy

Tuesday’s biggest gaining and declining stocks
3:56 p.m. March 22, 2011
- Kate Gibson

Prana shines in drugstock trading
10:02 a.m. March 22, 2011
- Val Brickates Kennedy

Prana rockets on Alzheimer's study
9:20 a.m. March 22, 2011
- Val Brickates Kennedy

Genervon ALS drug shows encouraging results

7:27 a.m. Oct. 20, 2014
- Seeking Alpha

Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog

1:00 p.m. Oct. 7, 2014
- Zacks.com

Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog

4:35 p.m. Sept. 8, 2014
- Zacks.com

Why Prana Biotechnology (PRAN) Stock Is Surging Today

8:46 a.m. Sept. 5, 2014
- TheStreet.com

Why Prana Biotechnology (PRAN) Stock Is Surging Today

1:05 p.m. July 17, 2014
- TheStreet.com

Prana shares up premarket on clinical trial update

8:22 a.m. July 17, 2014
- Seeking Alpha

Prana Biotechnology (PRAN) Stock Suddenly Surges

2:28 p.m. May 27, 2014
- TheStreet.com

Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure

3:15 p.m. April 14, 2014
- Seeking Alpha

Are These Three Biotech Companies Still Worth A Gamble?

10:16 a.m. April 14, 2014
- Seeking Alpha

Prana collapses after trial fails

5:57 a.m. March 31, 2014
- Seeking Alpha

Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors

2:49 p.m. March 20, 2014
- Seeking Alpha

Prana to join Aussie index for top 300 companies

9:00 a.m. March 11, 2014
- Seeking Alpha

Alzheimer's Research Stocks - Technical And Other Considerations

8:38 a.m. March 7, 2014
- Seeking Alpha

Prana Biotech Alzheimer approach supported by study

10:49 a.m. March 6, 2014
- Seeking Alpha

Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take?

3:24 p.m. March 4, 2014
- Seeking Alpha

Prana: Right Drug, Wrong Dose

9:38 a.m. March 3, 2014
- Seeking Alpha

Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results

6:45 a.m. March 1, 2014
- Seeking Alpha

Following The Latest In Alzheimer's Research As An Investor

10:12 a.m. Feb. 24, 2014
- Seeking Alpha

Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors

12:45 p.m. Feb. 22, 2014
- Seeking Alpha

SA PRO: Top Long And Short Ideas, Thursday February 20

7:30 a.m. Feb. 21, 2014
- Seeking Alpha

The Lancet Neurology Publishes Prana's Huntington
Disease Trial
11:01 a.m. Nov. 19, 2014
- BusinessWire - BZX

Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma
8:15 a.m. Sept. 11, 2014
- PR Newswire - PRF

Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
6:45 a.m. Sept. 5, 2014
- PR Newswire - PRF

Prana Alzheimer's disease Development Program update
3:10 p.m. July 17, 2014
- PR Newswire - PRF

Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
6:04 a.m. July 14, 2014
- PR Newswire - PRF

Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
4:10 a.m. July 14, 2014
- PR Newswire - PRF

Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology
6:10 a.m. June 11, 2014
- PR Newswire - PRF

Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics
10:29 a.m. May 19, 2014
- PR Newswire - PRF

World leader in movement disorders Professor Ira Shoulson joins Prana Board
6:30 a.m. May 14, 2014
- PR Newswire - PRF

Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
10:34 a.m. April 23, 2014
- PR Newswire - PRF

Zeldes Haeggquist & Eck LLP Announces Investigation of Prana
Biotechnology Limited
8:03 a.m. April 23, 2014
- BusinessWire - BZX

Prana Biotechnology Stock Hits New Low
9:47 a.m. April 16, 2014
- ACCESSWIRE

FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
8:49 a.m. April 2, 2014
- ACCESSWIRE

Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
1:00 a.m. April 1, 2014
- ACCESSWIRE

Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease
6:05 a.m. March 31, 2014
- PR Newswire - PRF

Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health
11:19 a.m. March 28, 2014
- PR Newswire - PRF

Huntington's Reviewed by NeuroPerspective
8:30 a.m. March 4, 2014
- PR Newswire - PRF

Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results
12:23 a.m. Feb. 19, 2014
- ACCESSWIRE

Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease
6:02 a.m. Feb. 18, 2014
- PR Newswire - PRF

Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana
8:00 a.m. Dec. 20, 2013
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advenica: Rising Star in Secure File Transfer Market

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

Europe's Largest Carbon Capture Facility Launches

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Sungrow's MGTL Series: A Game-Changer in Solar Tech

Smarter Energy Systems Are Here Gone are the days when solar inverters were just clunky bits of tech you threw on a roof. Sungrow's latest MGTL Series, revealed in Da Nang, marks a revolutionary step for Southeast Asia, Africa, Latin America, and beyond. They're not just talking the talk—they're bringing real innovation to the table. Why the MGTL Series Stands Out Look,...

Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Michigan Roof Inspections: Seasonal Insights That Count

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

53% of European Telecom Users Eye Provider Switch

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Overpricing in Atlanta Luxury Real Estate: Risks & Rewards

When Pricing Sends the Wrong Message Jump into the high stakes poker game of Atlanta's luxury real estate, and you'll find that pricing strategy is your make-or-break move. Jud Whitlock, a seasoned veteran over at Atlanta Fine Homes/Sotheby's International Realty, lays it all down: in this digital age, pricing too high is akin to waving a red flag at savvy buyers armed...

Thermoplastic Polyimide: A $0.86 Billion Market by 2032

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

DNOW Faces Class Action: Proxy Missteps Under Fire

DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...